Status:
ACTIVE_NOT_RECRUITING
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
Lead Sponsor:
University of Dundee
Conditions:
Hepatitis C Viral
Eligibility:
All Genders
Brief Summary
The aim of this study is to conduct an evaluation of hepatitis C treatments in NHS Tayside in order to empirically test the "treatment as prevention" models. This will be done by analysing the records...
Detailed Description
Hepatitis C is a blood-borne virus (HCV) that can seriously damage the liver and is spread mainly through blood-to-blood contact with an infected person. The "serious and significant public health ris...
Eligibility Criteria
Inclusion
- All individuals in NHS Tayside eligible for HCV testing and treatment according to Scottish Intercollegiate Guidelines Network guidelines.
Exclusion
- None
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
2800 Patients enrolled
Trial Details
Trial ID
NCT03356405
Start Date
April 1 2018
End Date
December 31 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHS Tayside
Dundee, United Kingdom, DD1 9SY